FDA Drug Recalls

Recalls / Class II

Class IID-0007-2026

Product

Norgestimate and Ethinyl Estradiol Tablets, USP, 0.18 mg/0.025 mg, 0.215 mg/0.025 mg, and 0.25 mg/0.025 mg, 3 Units, 3x28 tablets blister cards per carton, Rx only, Manufactured for AvKARE, Pulaski, TN 38478. Carton NDC: 42291-565-84; Blister NDC: 42291-565-28

Brand name
Norgestimate And Ethinyl Estradiol
Generic name
Norgestimate And Ethinyl Estradiol
NDC
42291-565
FDA application
ANDA091232
Affected lot / code info
Lot # LF41138A; Exp 06/30/2027

Why it was recalled

Failed Content Uniformity Specifications

Recalling firm

Firm
AvKARE
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
615 N 1st St, Pulaski, Tennessee 38478-2403

Distribution

Quantity
2192 cartons
Distribution pattern
U.S. Nationwide

Timeline

Recall initiated
2025-09-02
FDA classified
2025-10-06
Posted by FDA
2025-10-15
Status
Ongoing

Source: openFDA Drug Enforcement endpoint. Recall record D-0007-2026. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: Norgestimate And Ethinyl Estradiol · FDA Drug Recalls